Volasertib

Key Reference: 1)Rudolph et al. (2009) BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity; Clin. Cancer Res. 15 30942)Rudolph et al. (2015) Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia; J. Pharmacol. Exp. Ther. 352 5793)Ciceri et al. (2014) Dual kinase-bromodomain inhibitors for rationally designed polypharmacology; Nat. Chem. Biol. 10 305.

Molecular Weight: 618.82 g/mol.

Product Format: Powder.

Purity: > 98%.

• Artikelnummer: AVIOOMC00085-25
• Hersteller: Aviva Systems Biology
• Hersteller Artikelnummer: OOMC00085-25
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK